CCRM is a catalyst for commercializing regenerative medicine-based technologies and cell and gene therapies. We enable product development through the unique translational platforms that address the key bottlenecks in regenerative medicine commercialization.
CCRM provides innovative CDMO services to enable the development and commercialization of cell and gene therapies and regenerative medicine technologies. With our customer-focused approach customized to each client, we provide process development and GMP-compliant manufacturing services tailored to our clients’ timelines, financing, ambitions and needs.
From a hub with valuable technical information and resources to support the manufacturing of cell and gene therapies, to a blog that reveals an insider’s perspective on stem cells and regenerative medicine, to journal articles and white papers, our educational resources share everything you need to know.